ANI Pharmaceuticals/ US00182C1036 /
03/06/2024 21:59:49 | Chg. -1.38 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
63.51USD | -2.13% | 6,824 Turnover: 438,259.97 |
-Bid Size: - | -Ask Size: - | 65.43 | 63.36 |
GlobeNewswire
14:00
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
GlobeNewswire
29/05
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire
10/05
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
GlobeNewswire
18/04
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
GlobeNewswire
04/04
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
GlobeNewswire
03/04
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium
GlobeNewswire
29/02
ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides ...
GlobeNewswire
20/02
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
GlobeNewswire
29/01
ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Con...
GlobeNewswire
23/01
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP
GlobeNewswire
16/01
ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP
GlobeNewswire
22/11/2023
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
GlobeNewswire
08/11/2023
ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Gu...
GlobeNewswire
25/10/2023
ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m...
GlobeNewswire
02/10/2023
ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Pur...
GlobeNewswire
18/09/2023
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
GlobeNewswire
12/09/2023
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
GlobeNewswire
28/08/2023
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
GlobeNewswire
24/08/2023
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
23/08/2023
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors